HRT Financial’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $162K | Buy |
+77,200
| New | +$162K | ﹤0.01% | 1814 |
|
|
2025
Q1 | – | Sell |
-19,543
| Closed | -$25K | – | 2570 |
|
|
2024
Q4 | $25K | Buy |
+19,543
| New | +$25K | ﹤0.01% | 1966 |
|
|
2022
Q3 | – | Sell |
-14,817
| Closed | -$19K | – | 2857 |
|
|
2022
Q2 | $19K | Buy |
+14,817
| New | +$19K | ﹤0.01% | 2530 |
|
|
2021
Q4 | – | Sell |
-80,216
| Closed | -$311K | – | 3177 |
|
|
2021
Q3 | $311K | Sell |
80,216
-24,730
| -24% | -$95.9K | ﹤0.01% | 2153 |
|
|
2021
Q2 | $335K | Buy |
+104,946
| New | +$335K | ﹤0.01% | 1986 |
|
|
2018
Q4 | – | Sell |
-15,050
| Closed | -$90K | – | 621 |
|
|
2018
Q3 | $90K | Buy |
+15,050
| New | +$90K | 0.01% | 324 |
|